Symptoms of zinc deficiency can range from subtle to severe, affecting multiple body systems. Zinc is an essential trace element vital for immune function, wound healing, growth, and cellular processes. Whilst overt deficiency is uncommon in the UK, certain groups—including those with malabsorption disorders, dietary restrictions, or increased physiological demands—face elevated risk. Recognising the characteristic signs, such as skin rashes, recurrent infections, hair loss, and altered taste, enables timely diagnosis and treatment. Early intervention is crucial to prevent complications, particularly in children and vulnerable adults.

What Is Zinc Deficiency?

Zinc deficiency occurs when the body does not have sufficient zinc to maintain normal physiological functions. Zinc is an essential trace element required for numerous enzymatic reactions, immune function, protein synthesis, wound healing, DNA synthesis, and cell division. The body maintains limited zinc pools that are not readily exchangeable, making regular dietary intake crucial for maintaining adequate levels.

The condition can be classified as either acquired or inherited. Acquired zinc deficiency is far more common and typically results from inadequate dietary intake, malabsorption disorders, or increased physiological demands. Inherited forms, such as acrodermatitis enteropathica, are rare genetic conditions affecting zinc absorption in the intestine.

In the United Kingdom, overt zinc deficiency is relatively uncommon in the general population due to adequate dietary availability, though certain groups may be at higher risk according to National Diet and Nutrition Survey data. The recommended daily intake varies by age and physiological state: adults typically require 9.5 mg for men and 7 mg for women, with increased requirements during pregnancy and lactation.

Diagnosis can be challenging as serum zinc levels do not always accurately reflect total body zinc status. Results are affected by factors including the acute-phase response, pregnancy, hypoalbuminaemia, and time of day. Fasting morning samples are preferred, and results should be interpreted alongside CRP and albumin levels. Clinical assessment therefore relies on a combination of biochemical testing, dietary history, recognition of characteristic symptoms, and response to therapy. Early identification and treatment are important, as prolonged deficiency can lead to significant health effects, particularly on immune function, skin integrity, and growth in children.

Common Symptoms of Zinc Deficiency

The clinical presentation of zinc deficiency varies considerably depending on severity and duration. Dermatological manifestations are often the most recognisable features. Patients may develop a characteristic rash, particularly around body orifices (periorificial dermatitis), on the extremities, and in areas subject to friction. The skin lesions typically appear as erythematous, scaly, or eczematous patches that may become vesicular or pustular in severe cases. Delayed wound healing is another common cutaneous sign, with existing wounds showing poor granulation tissue formation and prolonged healing times.

Immune dysfunction represents a significant consequence of zinc deficiency. Patients experience increased susceptibility to infections, particularly respiratory and gastrointestinal infections, due to impaired T-cell function and reduced natural killer cell activity. Recurrent infections or unusually prolonged recovery from common illnesses may indicate underlying zinc insufficiency.

Hair and nail changes frequently occur. Hair loss (alopecia) may be diffuse or patchy, and hair texture often becomes brittle and lacklustre. Some patients may develop white spots on nails (leukonychia), though this is not specific to zinc deficiency and can have multiple causes. These changes reflect zinc's role in keratinocyte proliferation and protein synthesis.

Gastrointestinal symptoms include diarrhoea, loss of appetite, and altered taste sensation (dysgeusia) or smell (dysosmia). Patients often report that food tastes metallic or bland, which can further reduce dietary intake. Oral manifestations may include cheilitis (inflammation of the lips), glossitis, and stomatitis.

In children, growth retardation and delayed sexual maturation are particularly concerning manifestations. Zinc is critical for growth hormone function and gonadal development. Some patients may experience impaired cognitive function and mood disturbances, though these symptoms are non-specific and evidence in adults is limited. Severe deficiency, if left untreated, can lead to hypogonadism in males and complications during pregnancy including preterm delivery and low birth weight.

Seek urgent medical advice if an infant presents with the classic triad of periorificial/acral dermatitis, diarrhoea and hair loss, or if anyone experiences severe or recurrent infections, significant weight loss, or malabsorption symptoms alongside other features of zinc deficiency.

Who Is at Risk of Zinc Deficiency?

Several population groups face elevated risk of developing zinc deficiency due to physiological, dietary, or pathological factors. Individuals with malabsorption disorders constitute a major at-risk group. Conditions such as Crohn's disease, ulcerative colitis, coeliac disease, and short bowel syndrome impair zinc absorption in the small intestine. Patients who have undergone bariatric surgery, particularly Roux-en-Y gastric bypass, are at substantial risk due to reduced absorptive surface area and altered gastrointestinal anatomy, requiring monitoring as per British Obesity and Metabolic Surgery Society (BOMSS) guidelines.

Chronic liver disease and chronic kidney disease patients require careful monitoring. Hepatic cirrhosis affects zinc metabolism through reduced intake, malabsorption, and altered metabolism, whilst patients with chronic kidney disease, particularly those on dialysis, lose significant zinc through dialysate. Alcohol use disorder is associated with both reduced dietary intake and altered zinc metabolism, compounded by frequent concurrent liver disease.

Dietary factors play a crucial role. Strict vegetarians and vegans face higher risk because plant-based diets contain phytates (found in wholegrains, legumes, and nuts) that bind zinc and reduce its bioavailability. Whilst these foods contain zinc, the bioavailability is significantly lower than from animal sources. Elderly individuals are vulnerable due to reduced dietary intake, decreased absorption efficiency, polypharmacy, and increased prevalence of chronic diseases.

Pregnant and lactating women have increased zinc requirements to support foetal development and milk production. Inadequate supplementation during these periods can lead to maternal depletion. Exclusively breastfed infants may develop deficiency if complementary foods are not introduced from around 6 months, as breast milk zinc content decreases over time, aligning with NHS weaning guidance.

Additional risk groups include those with chronic diarrhoea, extensive burns, nephrotic syndrome, and patients receiving prolonged parenteral or enteral nutrition without adequate supplementation. Patients taking certain medications warrant monitoring. Long-term use of proton pump inhibitors and H2-receptor antagonists may affect zinc status in some patients, though clinical significance varies. Diuretics, penicillamine (used in Wilson's disease and rheumatoid arthritis), and certain other medications can increase zinc losses. Individuals with sickle cell disease often have increased zinc requirements due to chronic haemolysis and increased cellular turnover.

Treatment Options for Zinc Deficiency

Management of zinc deficiency involves both addressing the underlying cause and providing appropriate zinc supplementation. Oral zinc supplementation remains the first-line treatment for most patients with diagnosed deficiency. Zinc sulfate is the most commonly prescribed formulation in the UK, typically given under medical supervision at doses based on the British National Formulary (BNF) guidance. Zinc acetate and zinc gluconate are alternative preparations that may be better tolerated gastrointestinally. Treatment duration depends on severity but typically continues for 3–6 months, with clinical improvement often evident within 2–4 weeks.

Supplements should ideally be taken between meals to maximise absorption, as food, particularly those high in phytates, calcium, or iron, can reduce zinc bioavailability. However, if gastrointestinal side effects (nausea, abdominal discomfort) occur, taking zinc with food may improve tolerance, accepting slightly reduced absorption. Zinc supplements should be separated from several medications by at least 2-3 hours, including antibiotics (particularly tetracyclines and quinolones), penicillamine, bisphosphonates, levothyroxine, and iron or calcium supplements.

Dietary modification forms an essential component of management. Patients should be encouraged to consume zinc-rich foods including red meat, poultry, shellfish (particularly oysters), dairy products, eggs, nuts, seeds, and fortified cereals. A dietitian referral may benefit patients with complex dietary restrictions or malabsorption disorders to optimise nutritional intake whilst managing underlying conditions.

Addressing underlying causes is paramount for long-term management. Patients with malabsorption disorders require optimisation of their primary condition—for example, ensuring adequate disease control in inflammatory bowel disease or strict gluten avoidance in coeliac disease. Those with alcohol use disorder need appropriate support services and addiction management. Medication review should identify and, where possible, modify drugs contributing to zinc depletion.

Monitoring and follow-up should include clinical assessment of symptom resolution and, where appropriate, repeat serum zinc measurements after 3–6 months of treatment. For prolonged or high-dose therapy, monitoring should include full blood count and copper levels, as excessive zinc can induce copper deficiency. Clinical response often provides a more reliable indicator of treatment adequacy than biochemical markers alone.

Parenteral zinc administration is reserved for severe deficiency, patients unable to tolerate oral supplementation, or those with significant malabsorption where oral therapy proves ineffective. This typically occurs in hospital settings under specialist supervision. Excessive zinc supplementation should be avoided, as chronic intake above the UK upper limit (25 mg daily for adults) can cause copper deficiency, impair immune function, and interfere with iron metabolism. Patient education regarding appropriate dosing and duration is therefore essential. Any suspected adverse effects should be reported via the MHRA Yellow Card Scheme.

Frequently Asked Questions